SCHEMBL3982003

SCHEMBL3982003

CN1CCC(NCc2ccc(-c3ccc(S(C)(=O)=O)cc3)cn2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAICS P22234 1/20 0.48
LRRK2 Q5S007 2/20 0.43
KDM1A O60341 1/20 0.42
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
JAK3 P52333 1/20 0.41
MAP4K1 Q92918 1/20 0.39
GSK3B P49841 1/20 0.39
DYRK1A Q13627 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
IKBKB O14920 1/20 0.39
KCNH2 Q12809 1/20 0.39
GHSR Q92847 2/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC8 Q9BY41 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3983393 0.87 PAICS (0.43) PAICSLRRK2KDM1AMAOAMAOB
SCHEMBL5079876 0.82 GPR119 (0.56) GPR119
SCHEMBL25465723 0.75 HTR2A (0.45) PAICSKCNH2
SCHEMBL30983282 0.71 MEN1 (0.58) PAICSKDM1AMAOAMAOBHDAC1
SCHEMBL4972827 0.70 GPR119 (0.39) LRRK2KDM1AMAOAMAOBJAK3
SCHEMBL21753223 0.70 PTGS2 (0.51) MAOBKCNH2PTGS1PTGS2
SCHEMBL17674354 0.70 PTGS2 (0.48) MAOAMAOBKCNH2PTGS1PTGS2
SCHEMBL8423018 0.70 PTGS2 (0.51) KCNH2PTGS1PTGS2
SCHEMBL4387699 0.69 HTR2A (0.41) JAK2KCNH2GPR119
SCHEMBL13321381 0.69 VCP (0.49) KDM1AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2059516-A1 PYRIDINE COMPOUNDS FOR TREATING GPR119 RELATED DISORDERS BIOVITRUM AB (publ) (SE) 2009-05-20 EP disclosed
WO-2008025798-A1 PYRIDINE COMPOUNDS FOR TREATING GPR119 RELATED DISORDERS BIOVITRUM AB (PUBL) (SE) 2008-03-06 WO disclosed